-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Overweight on Replimune Group, Raises Price Target to $21

Benzinga·08/26/2026 13:39:36
语音播报
JP Morgan analyst Anupam Rama maintains Replimune Group (NASDAQ:REPL) with a Overweight and raises the price target from $20 to $21.